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Abstract: BACKGROUND Regional variation in healthcare utilization could reflect unequal access to
care, which may lead to detrimental consequences to quality of care and costs. The aims of this study were
to a) describe the degree of regional variation in utilization of 24 diverse healthcare services in eligible
populations in Switzerland, and b) identify potential drivers, especially health insurance-related factors,
and explore the consistency of their effects across the services. METHODS We conducted a cross-sectional
study using health insurance claims data for the year of 2014. The studied 24 healthcare services were
predominantly outpatient services, ranging from screening to secondary prevention. For each service,
a target population was identified based on applicable clinical recommendations, and outcome variable
was the use of the service. Possible influencing factors included patients’ socio-demographics, health
insurance-related and clinical characteristics. For each service, we performed a comprehensive method-
ological approach including small area variation analysis, spatial autocorrelation analysis, and multilevel
multivariable modelling using 106 mobilité spaciale regions as the higher level. We further calculated the
median odds ratio in model residuals to assess the unexplained regional variation. RESULTS Unadjusted
utilization rates varied considerably across the 24 healthcare services, ranging from 3.5% (osteoporosis
screening) to 76.1% (recommended thyroid disease screening sequence). The effects of health insurance-
related characteristics were mostly consistent. A higher annual deductible level was mostly associated
with lower utilization. Supplementary insurance, supplementary hospital insurance and having chosen
a managed care model were associated with higher utilization of most services. Managed care models
showed a tendency towards more recommended care. After adjusting for multiple influencing factors, the
unexplained regional variation was generally small across the 24 services, with all MORs below 1.5. CON-
CLUSIONS The observed utilization rates seemed suboptimal for many of the selected services. For all
of them, the unexplained regional variation was relatively small. Our findings confirmed the importance
and consistency of effects of health insurance-related factors, indicating that healthcare utilization might
be further optimized through adjustment of insurance scheme designs. Our comprehensive approach aids
in the identification of regional variation and influencing factors of healthcare services use in Switzerland
as well as comparable settings worldwide.
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Abstract
Background: Regional variation in healthcare utilization could reflect unequal access to care, which may lead to
detrimental consequences to quality of care and costs. The aims of this study were to a) describe the degree of
regional variation in utilization of 24 diverse healthcare services in eligible populations in Switzerland, and b)
identify potential drivers, especially health insurance-related factors, and explore the consistency of their effects
across the services.
Methods: We conducted a cross-sectional study using health insurance claims data for the year of 2014. The
studied 24 healthcare services were predominantly outpatient services, ranging from screening to secondary
prevention. For each service, a target population was identified based on applicable clinical recommendations, and
outcome variable was the use of the service. Possible influencing factors included patients’ socio-demographics,
health insurance-related and clinical characteristics. For each service, we performed a comprehensive
methodological approach including small area variation analysis, spatial autocorrelation analysis, and multilevel
multivariable modelling using 106 mobilité spaciale regions as the higher level. We further calculated the median
odds ratio in model residuals to assess the unexplained regional variation.
Results: Unadjusted utilization rates varied considerably across the 24 healthcare services, ranging from 3.5%
(osteoporosis screening) to 76.1% (recommended thyroid disease screening sequence). The effects of health
insurance-related characteristics were mostly consistent. A higher annual deductible level was mostly associated
with lower utilization. Supplementary insurance, supplementary hospital insurance and having chosen a managed
care model were associated with higher utilization of most services. Managed care models showed a tendency
towards more recommended care. After adjusting for multiple influencing factors, the unexplained regional
variation was generally small across the 24 services, with all MORs below 1.5.
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Conclusions: The observed utilization rates seemed suboptimal for many of the selected services. For all of them,
the unexplained regional variation was relatively small. Our findings confirmed the importance and consistency of
effects of health insurance-related factors, indicating that healthcare utilization might be further optimized through
adjustment of insurance scheme designs. Our comprehensive approach aids in the identification of regional
variation and influencing factors of healthcare services use in Switzerland as well as comparable settings worldwide.
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Background
A recent systematic review found a substantial evidence
base for large variation in the utilization of healthcare
services across regions, hospitals, and healthcare pro-
viders [1]. The ubiquity and persistence of such variation
cannot simply be explained by variation in the actual
care needs of different populations [2]. A substantial
portion may reflect inappropriate variability due to un-
equal access to care, potentially detrimental for quality
of care and costs [3]. This unwarranted component,
although difficult to quantify, should be minimized in
order to improve the quality, equity, and efficiency of
healthcare [4]. Regional variation may be driven by
multiple factors, including patient socio-demographics,
clinical characteristics, availability of physicians and
healthcare facilities, and healthcare system-related
factors [2]. They can function as personal, financial, and
organizational modifiers of access to care [5]. System-
related factors (e.g. relating to health insurance systems,
national legislation or programs) are of strong interest,
because their modification may offer big levers to reduce
unwarranted variation at a national level. We would re-
gard related findings as more meaningful and instructive
where same direction of effects is observed across
diverse healthcare services.
Existing studies of regional variation in utilization
mostly applied methods of small area variation analysis
(SAVA) [1]. Several problems were identified. First,
numerous analyses focused on only part of a country,
without nationwide coverage. Second, the selection of
studied healthcare services was often arbitrary and
opportunity-driven, suggesting that future studies should
focus on services of high clinical importance, policy
relevance, and public awareness. Third, the causes and
drivers of variation were rarely explored. Only few
studies controlled for a limited number of possible influ-
encing factors such as individual socio-demographics or
clinical characteristics [6, 7]. Finally, most studies
assessed the variation in utilization of a single service, or
one category of services (e.g. related surgical procedures)
[8, 9]. More comprehensive studies simultaneously
comparing a wider range of services are currently miss-
ing. Around 40% of studies of variation in healthcare
utilization used administrative data routinely collected
for billing purposes. Although subject to certain limita-
tions (e.g. restricted clinical information), health insur-
ance claims data play an important role in health
services research [10, 11].
In the present study, we aimed to select a variety of
healthcare services and their target populations based on
applicable clinical recommendations, and to describe the
degree of regional variation in their utilization in
Switzerland, a system with universal care access and
high out-of-pocket expenditures, using claims data.
Specific goals were to a) evaluate the degree of un-
adjusted and adjusted regional variation in utilization in
eligible populations, b) identify potential influencing fac-
tors, especially health insurance-related characteristics,
and c) explore the consistency of these factors’ effects
across the selected services.
Methods
Selection of healthcare services and eligible populations
Our study focused on primary healthcare for major non-
communicable diseases, and the selection of healthcare
services and the identification and extraction of the cor-
responding eligible populations were based on a system-
atic approach described earlier [12]. Recommendation
statements from clinical practice guidelines of Swiss,
European and relevant international medical societies,
used in Switzerland, were considered pragmatically
according to clinical relevance, expected frequency of
service use, size of the eligible population, and feasibility
to identify the population and service from Swiss health
insurance claims data. Some services outside primary
healthcare were included to extend the spectrum of
populations investigated and reflect services currently
debated in Switzerland.
The final selection consisted of 24 services reflecting
different categories of care, including screening (N = 4),
diagnosis (N = 6), primary prevention (N = 1), treatment
(N = 4) and secondary prevention (N = 9). Table 1 lists
descriptions of services, eligible populations, and recom-
mendation status, with details relevant for the extraction
of eligible study populations and service utilization infor-
mation from Swiss health insurance claims data through
a systematic approach.
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Table 1 Definition and description of selected 24 healthcare services
Category Healthcare service Service description
and frequency
Study population Recommendation
Screening Colon cancer screening Colonoscopy/ year Anyone 50–69 years old Colonoscopy should be done every
10 years for people 50–69 years old.
Breast cancer screening Mammography/ year 50–74 years old women Mammography should be done
every 2 years for 50–74 years old
women.
Prostate cancer screening Prostate-specific
antigen (PSA)
testing/ year
50–70 years old men Routine prostate cancer screening
with PSA testing is not
recommended.
Osteoporosis screening Dual-energy x-ray
absorptiometry
(DXA)/ year
People over 60 and with
risk factorsa of spontaneous
fractures
DXA densitometry is
recommended for patients with
spontaneous fractures or increased
risk of them.
Diagnosis DM: HbA1c test Glycated hemoglobin
(HbA1c) test twice/ year
Adult drug-treated diabetes
patients
HbA1c test should be done for
diabetes patients at least twice a
year.




Albuminuria and serum creatinine
tests should be done for diabetes
patients at least once a year.
DM: LDL test Low-density lipoprotein
(LDL) test/ year
Adult drug-treated diabetes
patients under 75 years old
LDL test should be done for
diabetes patients at least once a
year.




Eye exam should be performed for




without T3 and T4 tests
on the same day
Adults without thyroid
disease and receiving TSH
test
TSH should be measured as an
initial screening test for hypo/
hyperthyroidism, while T3 and T4









Routine chest radiography is not
recommended before surgery.
Primary prevention Influenza vaccination Influenza outpatient
vaccination/ year
People over 65 years old
or with a specified chronic
conditionb
People over 65 years old and
patients with chronic conditions,
specified by Federal Office of
Public Health, should be
vaccinated against influenza every
year.
Treatment BZD Cumulative prescription
of benzodiazepines
(BZD) for > 8weeks/ year
Anyone over 65 years old Long-term use of benzodiazepines




inhibitors (PPI) or H2
histamine receptor




PPI should not be used at maximal
dose for prolonged periods of
time.





procedures (either as in-
or outpatient)
If none of the special conditions
apply, certain surgical procedures







C-section should not be performed
unless absolute or relative
indications are present.
Secondary prevention AMI: aspirin Aspirin prescription
within 2 weeks after
acute myocardial
infarction (AMI)
Adult patients with AMI All myocardial infarction patients
should take aspirin long-term.
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Study design and populations
Our cross-sectional study used mandatory health insur-
ance claims data provided by Helsana, one of the largest
health insurers in Switzerland. The underlying database
covered around 1.2 million people, 15% of the Swiss
population. The eligible population for each healthcare
service was identified from persons enrolled with
Helsana during 2014 (Table 1). Asylum seekers, Helsana
employees, enrolees living outside Switzerland, with
incomplete address information, or living in nursing
Table 1 Definition and description of selected 24 healthcare services (Continued)
Category Healthcare service Service description
and frequency
Study population Recommendation
AMI: statin High-dose statin
prescription within
2 weeks after AMI
Adult patients with AMI All myocardial infarction patients
should get statins long-term.
AMI: beta-blocker Beta-blocker
prescription within
2 weeks after AMI
Adult patients with AMI All myocardial infarction patients
with heart failure or impaired
function should get beta-blockers
long-term.






within 2 weeks after
AMI
Adult patients with AMI All myocardial infarction patients
with heart failure or impaired
function should get ACE or ARB
antihypertensive medication
long-term.
AMI: P2Y P2Y antiplatelet druge
prescription within
2 weeks after AMI
Adult patients with AMI All myocardial infarction patients
should get P2Y antiplatelet drugs
for at least 1–12months according
to the bleeding risk profile and
AMI treatment.
PPI with NSAID PPI prescription within





Adult patients with a
cumulative NSAID
prescription of > 8 weeks
at maximal dose
Patients taking long-term NSAID
and with risk factors for gastric
ulcerf should also take PPI.
PAD: statin Prescription of statins






Statins are recommended for all
patients with PAD.
Afib: anticoagulation Oral anticoagulation
prescription within
2 weeks after atrial
fibrillation (Afib)
identification
Adult patients with atrial
fibrillation diagnosis and
additional risk factorsg
All patients with atrial fibrillation
should be prescribed oral
anticoagulation for embolic events










Adult patients with a new
prescription of DMARD by
a rheumatologist
Short-term glucocorticoids should
be taken with newly prescribed
DMARD.
a. Recent distal radius, proximal humerus, vertebral or femoral fracture, use of drugs increasing the risk of osteoporosis, use of oral glucocorticoids, diabetes,
ankylosing spondylitis, osteogenesis imperfecta, rheumatoid arthritis, inflammatory bowel disease, Cushing’s disease, alcohol or nicotine abuse, chronic liver
disease, gastrectomy, malnutrition, hypogonadism, hyper- or hypothyroidism, and hyperparathyroidism. Patients currently treated or diagnosed with osteoporosis
were excluded
b. Cardiovascular disease, chronic pulmonary disease, diabetes, chronic liver disease, renal failure, immune deficiency, systemic neurologic disorders
c. Varicose veins ligation and stripping, surgical procedures of hemorrhoids, inguinal hernia and cervix, knee arthroscopy and meniscectomy, tonsillectomy
d. Placental, umbilical cord or fetal pathology, HIV or genital HSV infection, or multiple pregnancy
e. Clopidogrel, prasugrel or ticagrelor
f. Concurrent use of antiplatelet, anticoagulant drugs, oral glucocorticoids or recent hospitalization with any major bleeding
g. Risk factors (congestive heart failure, hypertension, age 65–74 or ≥ 75 years old, diabetes, previous stroke, transient ischemic attack, or thromboembolism,
cardiovascular disease, female sex) were extracted from available claims data and summed according to CHA2DS2-VASc score. Patients with CHA2DS2-VASc score
of ≥2 for males and ≥ 3 for females were included
DM Diabetes mellitus
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homes with lump-sum reimbursement of some health-
care services were excluded.
Swiss mandatory health insurance covers a federally
defined, uniform benefit package for anyone living in
Switzerland regardless of health status. A higher annual
deductible (of Swiss Francs 500, 1000, 1500, or 2500)
can be chosen instead of the legal minimum of 300, im-
plying lower premiums. People can also choose between
standard fee-for-service and managed care models [13,
14], the latter requiring a specific general practitioner or
telemedicine provider as the first contact for a new
health problem, and resulting in lower premiums. In
addition to mandatory insurance, a variety of supple-
mentary insurance products can be bought, for instance,
supplementary hospital insurance allowing for hospitalization
in semiprivate or private wards.
The data provided by Helsana were anonymized.
According to the national ethical and legal regulations,
ethical approval was not needed for this type of analysis.
This was confirmed by a waiver of the competent ethics
committee (Kantonale Ethikkommission Zürich, dated
11th January 2017, BASEC-Nr. Req-2017-00011).
Outcome and explanatory variables
For each of the selected services, the outcome variable was
whether the service was used by each member of the
eligible population (Table 1). Candidate explanatory vari-
ables available for all 24 healthcare services included a)
socio-demographics, i.e. age, gender, language region, pur-
chasing power index, and urban/rural residence, b) health
insurance-related characteristics, including having any
supplementary insurance, having supplementary hospital
insurance, choice of a standard or managed care model,
choice of annual deductible, c) number of chronic comor-
bidities as indicated by pharmaceutical cost groups [15].
In people with supplementary hospital insurance, we
could not distinguish the additional presence of other sup-
plementary insurances but only evaluate a mixed effect.
To verify the effect of supplementary hospital insurance,
we performed sensitivity analyses using different combina-
tions of available explanatory variables. We further in-
cluded service-specific clinical conditions of relevance and
a few service-specific non-individual level variables. We
could include regional-level factors in the analysis for four
selected healthcare services. For preoperative chest radiog-
raphy (POCR), the type of hospital performing the surgery
(central, primary, surgical, or other specialized hospital)
was considered. For breast cancer screening, we deter-
mined if a cantonal-level breast cancer screening program
existed. Analysis of eye examinations in diabetes patients
considered ophthalmologist density per 10,000 inhabitants
in each region. For surgical procedures recommended to
be performed in outpatient settings, hospital bed density
per 1000 inhabitants in each region was considered.
Geographic units
We used spatial mobility regions (mobilité spatiale - MS)
as the geographic level of analysis (N = 106). MS regions
are defined by the Swiss Federal Statistical Office and used
as intermediate-size units of analysis for scientific and
regional policy purposes [16]. Each study participant’s
residence was assigned to the corresponding MS region.
Statistical analysis
A four-step analytical approach was applied to all
selected healthcare services. In the first step, we descrip-
tively analysed each study population’s characteristics.
Second, we calculated raw utilization rates per MS re-
gion and described the degree of regional variation using
small area variation analysis (SAVA). We computed
extremal quotient (EQ), interquartile range (IQR), coeffi-
cient of variation (CV) and systematic component of
variation (SCV). SCV estimates the systematic compo-
nent of variation between small regions by subtracting
the component of random variation from total variation,
considering age and sex [8, 17]. SCV has been demon-
strated to perform generally well in the identification
and quantification of variation beyond chance, and has
often been used to compare the variability of different
healthcare services [18, 19]. Compared to EQ, IQR and
CV, which are simple descriptive statistics, SCV is
considered more reliable. Therefore, we used SCV as the
main estimate to evaluate the degree of regional vari-
ation in healthcare utilization before multivariable ad-
justment. SCV values above 3, between 5.4 and 10, and
above 10 suggest relevant, considerable, and very high
variation in utilization, respectively [20]. We further
checked spatial autocorrelation of regional utilization
rates with global Moran’s I statistic [21]. Moran’s I mea-
sures the correlation of a variable with itself across space,
ranging from − 1 to 1. Moran’s I close to 0 suggests ran-
dom distribution across space. Significantly positive (nega-
tive) Moran’s I values indicate that neighbouring regions
are more similar (dissimilar) than distant regions.
Third, to correctly represent the nested data structure,
to have more precise standard error estimates, and to as-
sess the variation between regional units, we performed
two-level logistic regression modelling with individuals
as the lower-level and MS regions as the higher-level of
analysis. For POCR, a cross-classified model was devel-
oped, with hospitals where surgeries were performed as
an additional level cross-classified with MS regions, as
we assumed an impact of hospitals on POCR utilization
[22]. A sensitivity analysis used our standard, two-level
approach. Inclusion of explanatory variables was based
on the deviance information criterion [23]. We calcu-
lated multivariable-adjusted odds ratios (ORs) and 95%
confidence intervals (95%CIs) to estimate the effect of
explanatory variables on utilization.
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In the last step, we assessed the degree of unexplained
regional variation after multilevel modelling by calculat-
ing median odds ratios (MORs) and variance partition
coefficients (VPCs). MOR is extrapolated from the vari-
ance of random effects in multilevel models. It compares
the adjusted odds of using the analysed service in two
individuals with identical characteristics, but living in
two randomly selected regions. The median of all pos-
sible resulting ORs is defined as MOR. MOR is always
above one, as the higher-propensity region is always
compared with the lower-propensity region for the out-
come of interest. VPC represents the proportion of total
variation accounted for systematic differences between
MS regions. The interpretation of the magnitude of
MOR should be related to VPC [24]. A relatively big
MOR in combination with a considerable VPC indicates
substantial regional variation [24]. In addition, we
checked for spatial autocorrelation in model residuals
across MS regions to check the modelling assumption of
independence of regional units, again using global
Moran’s I statistic [25, 26].
Statistical analyses were performed using R 3.4.4 [27],
STATA 13, and MLwiN 3.04 [28] integrated in STATA
using the runmlwin package [29]. Spatial autocorrelation
analysis was done with GeoDa 1.10 [30]. The results




Across the 24 selected healthcare services, eligible popu-
lation size ranged from 409,960 for influenza vaccination
to 1992 for new prescription of a disease-modifying anti-
rheumatic drug (DMARD) that should be prescribed
concomitantly with a glucocorticoid (Table 2). The mean
age of populations ranged from 31.9 years (women giv-
ing birth without absolute indications for C-section), to
80.8 years (patients with atrial fibrillation and indication
Table 2 Basic characteristics of study populations for selected 24 healthcare services
Service category Healthcare service Total Number Age (mean, sd) Female gender Utilization rate
Screening Colon cancer screening 276,387 58.6 (5.8) 142,675 (51.6%) 5.9%
Breast cancer screening 178,145 61.0 (7.2) – 20.9%
Prostate cancer screening 145,874 59.1 (6.2) – 28.4%
Osteoporosis screening 97,237 72.5 (8.5) 60,812 (62.5%) 3.5%
Diagnosis DM: HbA1c test 49,198 66.6 (13.0) 22,138 (45.0%) 69.6%
DM: kidney exam 49,198 66.6 (13.0) 22,138 (45.0%) 44.3%
DM: LDL test 33,975 60.1 (11.2) 13,977 (41.2%) 44.3%
DM: eye check 49,198 66.6 (13.0) 22,138 (45.0%) 55.5%
TSH 169,232 56.8 (18.5) 111,847 (66.1%) 76.1%
POCR 47,215 60.3 (17.2) 27,086 (57.4%) 13.0%
Primary prevention Influenza vaccination 409,960 64.1 (16.3) 230,202 (56.2%) 20.9%
Treatment BZD 243,951 75.0 (7.6) 141,986 (58.2%) 18.6%
PPI 153,523 55.7 (17.8) 93,543 (60.9%) 55.5%
Outpatient procedures 10,656 50.5 (13.7) 7719 (72.4%) 61.4%
C-section 9449 31.9 (5.1) – 28.5%
Secondary prevention AMI: aspirin 2232 72.4 (13.7) 801 (35.9%) 47.0%
AMI: statin 2232 72.4 (13.7) 801 (35.9%) 34.2%
AMI: beta-blocker 2232 72.4 (13.7) 801 (35.9%) 42.1%
AMI: ACE/ARB 2232 72.4 (13.7) 801 (35.9%) 43.8%
AMI: P2Y 2232 72.4 (13.7) 801 (35.9%) 46.8%
PPI with NSAID 95,072 61.0 (16.2) 60,804 (64.0%) 43.5%
PAD: statin 23,868 63.6 (16.5) 12,113 (50.7%) 28.5%
Afib: anticoagulation 8291 80.8 (7.9) 4037 (48.7%) 27.5%
GKK 1992 59.2 (15.3) 1369 (68.7%) 58.7%
sd Standard deviation, DM Diabetes mellitus, HbA1c Glycated hemoglobin, LDL Low-density lipoprotein, TSH Thyroid stimulating hormone, POCR Outpatient
preoperative chest radiography, BZD Benzodiazepines, PPI Proton pump inhibitor, C-section Cesarean section, AMI Acute myocardial infarction, ACE Angiotensin
converting enzyme, ARB Angiotensin receptor blocker, P2Y Clopidogrel, prasugrel or ticagrelor, NSAID Nonsteroidal anti-inflammatory drug, PAD Peripheral artery
disease, Afib Atrial fibrillation, GKK Glucocorticoid
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for oral anticoagulation). Overall utilization varied from
3.5% of older people with risk factors for fractures
receiving osteoporosis screening, to 76.1% of eligible
people receiving a thyroid-stimulating hormone (TSH)
test as recommended.
Effects of explanatory variables
After multivariable adjustment, we observed inconsistent
associations between socio-demographic variables and
healthcare utilization (Additional file 1: Supplementary
Table 1). Age showed a nonlinear effect in most cases;
utilization typically reached a peak between 50 and 70
years and then decreased (Additional file 3: Supplemen-
tary Fig. 1). Gender effects were mostly not prominent.
However, there was an OR of 3.66 (95%CI: 3.10, 3.99)
for osteoporosis screening use in women, while the OR
for statin prescription in women with peripheral artery
disease was 0.52 (95%CI: 0.49, 0.55). Having more co-
morbidities was significantly associated with increased
use of most services, but not secondary prevention
medication after acute myocardial infarction (AMI) or
oral anticoagulation in patients with atrial fibrillation.
The effects of health insurance-related characteristics
were mostly consistent across the 24 healthcare services.
Having chosen a managed care model was significantly
associated with increased use of most services in the cat-
egories of screening, diagnosis and secondary prevention,
but decreased use of the four services in the treatment cat-
egory (three of which were not recommended; the fourth
were surgical procedures in the outpatient setting) (Fig. 1).
Fig. 1 Effects of managed care models on healthcare services utilization. *Indicates services that are discouraged and therefore an odds ratio < 1
indicates better conformity with recommendations, for all other services, an odds ratio > 1 indicates greater use and better guideline conformity. OR:
odds ratio; CI: confidence interval; DM: diabetes mellitus; DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated hemoglobin; LDL: low-density
lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest radiography; BZD: benzodiazepines; PPI: proton pump inhibitor; C-
section: Cesarean section; AMI: acute myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker; P2Y: clopidogrel,
prasugrel or ticagrelor; NSAID: nonsteroidal anti-inflammatory drug; PAD: peripheral artery disease; Afib: atrial fibrillation; GKK: Glucocorticoid
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The strongest effect was noted for C-section, with an OR
of 0.81 (95%CI: 0.73, 0.91). Having any supplementary in-
surance was associated with increased use of most services
(Fig. 2). A negative effect was again seen for C-section,
with an OR of 0.86 (95%CI: 0.77, 0.96). Having supple-
mentary hospital insurance was also associated with in-
creased use of most services, including C-section with an
OR of 1.58 (95%CI: 1.37, 1.83). People with supplementary
hospital insurance were also more likely to undergo surgi-
cal procedures with potential for being performed in the
outpatient setting, as inpatients (Fig. 3). Related sensitivity
analyses showed consistent results. Having a higher de-
ductible was associated with lower utilization of most
healthcare services (Fig. 4). All ORs and 95%CIs resulting
from the multilevel models for 24 healthcare services are
shown in Additional file 1: Supplementary Table 1.
Service-specific factors were associated with healthcare
utilization. Patients having surgery in primary, surgical
and other specialized hospitals were more likely to re-
ceive POCR than patients in central hospitals. Residing
in a canton with a coordinated breast cancer screening
program was associated with increased mammography
utilization with an OR of 1.80 (95%CI: 1.66, 1.97). Asso-
ciations of ophthalmologist density with eye examina-
tions in diabetes patients with an OR of 1.09 (95%CI:
0.93, 1.23) and of hospital bed density with having surgi-
cal procedures in the outpatient setting with an OR of
0.97 (95%CI: 0.94, 1.01)) were non-significant.
Fig. 2 Effects of supplementary insurance on healthcare services utilization. *Indicates services that are discouraged and therefore an odds
ratio < 1 indicates better conformity with recommendations, for all other services, an odds ratio > 1 indicates greater use and better guideline
conformity. OR: odds ratio; CI: confidence interval; DM: diabetes mellitus; DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated hemoglobin;
LDL: low-density lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest radiography; BZD: benzodiazepines; PPI:
proton pump inhibitor; C-section: Cesarean section; AMI: acute myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin
receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: nonsteroidal anti-inflammatory drug; PAD: peripheral artery disease; Afib: atrial
fibrillation; GKK: Glucocorticoid
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Unadjusted and adjusted regional variation
Figure 5 illustrates the degree of unadjusted regional
variation across 24 healthcare services; full numerical re-
sults are presented in Additional file 2: Supplementary
Table 2. The SCVs of six selected healthcare services
were above three, indicating that relevant regional vari-
ation in the utilization of these services. Among them,
the SCVs for POCR (13.24), breast cancer screening
(12.88), and long-term benzodiazepine use in older
people (9.97) were around or above ten, indicating large
regional variation.
Figure 6 shows the degree of unexplained regional
variation after controlling for the available influencing
factors through multilevel modelling. MORs were below
1.5 for all selected services, and mostly below 1.3. The
biggest MOR, close to 1.5, was found for TSH testing,
and the smallest MOR, which was just above 1.1, was
found in taking aspirin for secondary prevention of
AMI. VPCs for all 24 services were within 5.0%, and
mostly below 2.0% (Additional file 2:Supplementary
Table 2). The combination of relatively small MORs and
VPCs implied small unexplained variation for all 24 ser-
vices. The MOR for POCR in the cross-classified model
was 1.25 versus 1.46 in sensitivity analysis, suggesting
that some variation among MS regions was accounted
for by considering the hospital level.
We detected significant spatial dependence (indicated
by significant global Moran’s I value) in raw utilization
rates across MS regions for 16 selected healthcare ser-
vices. After multivariable adjustment through multilevel
Fig. 3 Effects of supplementary hospital insurance on healthcare services utilization. *Indicates services that are discouraged and therefore an
odds ratio < 1 indicates better conformity with recommendations, for all other services, an odds ratio > 1 indicates greater use and better
guideline conformity. OR: odds ratio; CI: confidence interval; DM: diabetes mellitus; DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated
hemoglobin; LDL: low-density lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest radiography; BZD:
benzodiazepines; PPI: proton pump inhibitor; C-section: Cesarean section; AMI: acute myocardial infarction; ACE: angiotensin converting enzyme;
ARB: angiotensin receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: nonsteroidal anti-inflammatory drug; PAD: peripheral artery
disease; Afib: atrial fibrillation; GKK: Glucocorticoid
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modelling, global Moran’s I values in model residuals
generally decreased, and significant, moderate spatial de-
pendence was detected for only six healthcare services.
(Additional file 2: Supplementary Table 2).
Discussion
We studied 24 diverse healthcare services recommended
or discouraged for target populations in clinical guide-
lines, mainly for major chronic diseases. Overall
utilization rates varied substantially, and suggested sub-
optimal utilization for many services. After controlling
for multiple influencing factors, the unexplained regional
variation was generally small. Associations between
health insurance-related characteristics and utilization
were mostly consistent; associations with other influ-
ences were rather service-specific.
Although there are no “appropriate” or “optimal”
utilization rates known for many healthcare services,
(See figure on previous page.)
Fig. 4 Effects of annual deductible level (Swiss Francs) on healthcare services utilization. OR: odds ratio; CI: confidence interval; DM: diabetes
mellitus; DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated hemoglobin; LDL: low-density lipoprotein; TSH: thyroid stimulating hormone;
POCR: outpatient preoperative chest radiography; BZD: benzodiazepines; PPI: proton pump inhibitor; C-section: Cesarean section; AMI: acute
myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID:





Fig. 5 Degree of unadjusted regional variation across 24 selected healthcare services. The blank circle means that for some services, EQ and SCV
are not applicable due to insufficient study population. DM: diabetes mellitus; DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated
hemoglobin; LDL: low-density lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest radiography; BZD:
benzodiazepines; PPI: proton pump inhibitor; C-section: Cesarean section; AMI: acute myocardial infarction; ACE: angiotensin converting enzyme;
ARB: angiotensin receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: nonsteroidal anti-inflammatory drug; PAD: peripheral artery
disease; Afib: atrial fibrillation; GKK: Glucocorticoid
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strongly recommended services supported by sound evi-
dence may be considered as effective care, and expected
to be highly utilized in eligible populations. For example,
the studied tests for diabetes complications and second-
ary prevention medications for AMI patients would fall
into this category. Utilization rates for these services be-
tween 34 and 70% indicated suboptimal utilization. The
utilization rates of healthcare services discouraged in
clinical guidelines were generally low as expected. It was
also noted that cancer screening rates were apparently
very low, presumably because their performance is not
recommended annually and we only analysed data from
2014. More accurate estimates can be achieved if consid-
ering the recommended screening intervals [31].
The effects of explanatory variables reflected, to
some extent, barriers to and facilitators of access to
care. In particular, we found coherent associations
with health insurance-related characteristics, in a set-
ting with mandatory insurance and quasi-universal ac-
cess. The data indicated a negative dose-response
effect of deductible level on utilization. People with
higher deductibles tend to be healthier and willing to
take more risks, and some of their invoices may be
missed, which may partially explain this observation.
However, higher out-of-pocket costs may also make
people more reluctant to use services, constituting a
financial barrier [32]. While non-insurance practically
does not occur in Switzerland, foregoing healthcare
utilization due to out-of-pocket costs has been previ-
ously documented [33–35]. People having supplemen-
tary insurance in addition to mandatory insurance
may be wealthier, and more health-conscious and
Fig. 6 Degree of adjusted regional variation across 24 selected healthcare services. MOR: median odds ratio; CrI: credible interval; DXA: Dual-
energy x-ray absorptiometry; TSH: thyroid stimulating hormone; DM: diabetes mellitus; POCR: outpatient preoperative chest radiography; HbA1c:
glycated hemoglobin; LDL: low-density lipoprotein; C-section: Cesarean section; BZD: benzodiazepines; PPI: proton pump inhibitor; AMI: acute
myocardial infarction; Afib: atrial fibrillation; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker; P2Y: clopidogrel, prasugrel or
ticagrelor; PAD: peripheral artery disease; GKK: Glucocorticoid; NSAID: nonsteroidal anti-inflammatory drug
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educated on average. Thus, they may seek, or be willing
to accept more care, as we observed for most services.
Having supplementary hospital insurance was in general
associated with increased utilization of healthcare services.
This effect was especially prominent in the case of C-
section, which is, to a large extent, a preference-sensitive
service [36]. Expectedly, having supplementary hospital in-
surance also made it more likely for patients to receive
specific surgical procedures, recommended to be per-
formed on an outpatient basis, as inpatients Enrolees in
managed care models were more likely to use healthcare
in two thirds of the studied services, which were mostly
recommended ones. This may be partially explained by
more health awareness. It may also imply that managed
care models provide better coordinated and more
guideline-concordant care.
Associations between socio-demographics and health-
care utilization were largely service specific. Effects of
language region were not consistent, which may be due
to different culture and norms, regional health interven-
tion programs, and different practice styles of healthcare
providers [37, 38].
People with more comorbidities were generally more
likely to use healthcare services. Worse health may trig-
ger more awareness of health-related issues and more
contact with healthcare providers, leading to further
care. Exceptions were secondary prevention medications
in AMI patients and oral anticoagulation in atrial fibril-
lation patients. Previous studies also reported that more
comorbidities were associated with poor adherence to
related recommendations [39, 40].
SAVA detected six healthcare services with SCV
values over three, among which breast cancer screen-
ing, POCR, and long-term use of benzodiazepines in
older people had SCVs around ten, suggesting large
regional variation. However, after adjusting for avail-
able influencing factors, all MORs were relatively
small (1.14–1.49). Together with VPCs below 5%, this
indicated that the unexplained regional variation in
utilization of all considered services was small [24].
The largest unexplained variation was found for TSH
testing and surgical procedures performed in the out-
patient setting. Both represent preference-sensitive
care and decision-making may strongly depend on
physicians’ preferences and clinical opinions. Only few
previous studies have comprehensively assessed and
compared variation in utilization across multiple
healthcare services, with mixed results. One study re-
ported moderate variation with MORs between 1.27
to 1.74 for some diabetes-related primary care ser-
vices [7]. Another study reported large variation with
MORs between 2.3 to 21.5 for intensive care unit
(ICU) use after 13 major surgical procedures across
hospitals [6].
In addition to relatively small regional variation across 24
healthcare services, we found moderate spatial autocorrel-
ation, that is, spatial dependence in the unexplained re-
gional variation in utilization for several healthcare services.
Further research could assess the spatial clustering of such
regional variation, to explore potential overarching patterns
across services, and possibly identify regions with generally
superior or inferior performance in terms of appropriate
healthcare utilization. This might provide valuable insights
for local healthcare intervention and promotion programs.
Strengths and limitations
Our study has a number of strengths. First, we used a
large dataset representing all regions of Switzerland,
resulting in large sample sizes for most of the studied
healthcare services. Second, we assessed multiple, diverse
services, enabling comparison and a broader perspective.
The health insurance claims data used provided detailed
information on individual insurance-related characteris-
tics, allowing in-depth analyses. Finally, we performed
multilevel multivariable modelling for efficient control of
confounding.
Several limitations should be considered. First, our se-
lection of healthcare services and eligible populations was
not entirely based on burden of disease criteria, mainly be-
cause of limitations dictated by the characteristics of Swiss
claims data. Second, clinical information is limited in the
claims data; outpatient diagnoses are lacking. This may
have led to a certain extent of misclassification of eligibil-
ity for and utilization of services. Third, we used claims
data from a single insurer. Enrolees of other health in-
surers may theoretically have different characteristics and
patterns of healthcare utilization. However, the claims
data were based on 1.2 million people from all regions in
Switzerland. The benefit package of the mandatory insur-
ance is federally defined and identical for all health in-
surers. Thus, we expect little deviation of enrollees’
characteristics compared to the whole Swiss population,
and the results should essentially be generalizable to the
entire country. Fourth, we cannot exclude high variation
across different types of units, e.g. healthcare providers for
whom we had no detailed information. Finally, the possi-
bility of endogeneity in the relationship between health
insurance-related factors and healthcare utilization could
not be ruled out in our study. The health status and
utilization of healthcare services could to a certain degree
impact the choice of health insurance status, and therefore
the observed insurance effects might be biased. However,
previous studies tried to deal with endogeneity by imple-
menting instrumental variable approaches. They found
that the effects of insurance status increased in com-
parison with analyses non-instrumented on both
healthcare utilization and health status [41, 42]. While
we are unable to provide a formal assessment,
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analyses not addressing endogeneity may even under-
estimate health insurance effects.
Conclusions
Our study is the first to collectively evaluate regional
variation in the utilization of diverse healthcare ser-
vices and related influencing factors, with a particular
focus on insurance-related characteristics. Regional
variation in utilization that remained unexplained
after multivariable adjustment was relatively small,
implying only limited local variation. The consistent
effects of health insurance-related factors on health-
care utilization and variation are worth special atten-
tion. Despite remaining uncertainties, they suggest
that healthcare utilization might be further optimized
and a better-performed healthcare system might po-
tentially be achieved through adjustment of health
insurance design. For instance, managed care models,
which seemed to offer better coordinated, more
guideline-adherent care, could be further financially
encouraged. Rules regarding annual deductible levels
could also be considered to be adjusted, especially for
certain types of effective care with strong medical evi-
dence, in order to reduce financial barriers to access.
Our comprehensive approach aids in the identification
of regional variation and influencing factors of health-
care services use in Switzerland as well as comparable
settings worldwide.
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